- £4.78bn
- £5.13bn
- £1.20bn
- 79
- 15
- 86
- 65
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 545 | 538 | 787 | 1,013 | 1,200 |
Cost of Revenue | |||||
Gross Profit | 197 | 194 | 288 | 375 | — |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 461 | 469 | 683 | 869 | 1,017 |
Operating Profit | 84.1 | 69.8 | 104 | 144 | 183 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 83.5 | 66.7 | 96.6 | 130 | 156 |
Provision for Income Taxes | |||||
Net Income After Taxes | 62.4 | 49.8 | 69.7 | 95.4 | 118 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 61.9 | 49.3 | 69.8 | 94.7 | 118 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 61.9 | 49.3 | 69.8 | 94.7 | 118 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.543 | 0.474 | 0.617 | 0.787 | 1.14 |
Dividends per Share |